Remove 2023 Remove Biotechnology Remove Ecosystems
article thumbnail

Pharmaceutical Outsourcing Evolution: The Rise of Clinical Peripheral Services

Frost & Sullivan

Regional Insights: The Growing Market for CROs in Asia-Pacific Asia-Pacific continues as a high-growth region for clinical contract peripheral services, driven by expanding healthcare infrastructure, increasing trial activity, and the regions cost-effective research ecosystem.

article thumbnail

The Global Growth of Cardiac Biomarkers Diagnostics: Innovations, Growth Drivers, and Opportunities (2024-2029)

Frost & Sullivan

Competitive Landscape: Industry Players and Ecosystem The global cardiac biomarkers diagnostics market is moderately competitive, with major players driving innovation. Elabscience Biotechnology, Inc., Elabscience Biotechnology, Inc., Quanterix, Response Biomedical Corp., Tosoh Bioscience, Tulip Diagnostics Pvt.

article thumbnail

JP Morgan Healthcare Conference 2025: Key Growth Opportunities Shaping the Future of Pharma and Biotechnology

Frost & Sullivan

The 43rd JP Morgan Healthcare Conference , held from January 1316, 2025, in San Francisco, brought together a vibrant ecosystem of global pharma stakeholders, innovative startups, emerging biotech companies, and investors.